Jiangsu Hanbon Science and Technology
688755
ZERUN CO., LTD
301636
SENXUAN
830946
4
Greenworks
301260
5
Tuoxin Pharmaceutical Group
301089
(Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | 21.71%33.27M | 8.12%122.98M | 6.75%34.77M | 5.20%31.52M | 15.21%29.36M | 6.24%27.33M | 4.18%113.74M | 11.37%32.57M | 10.24%29.96M | -0.76%25.49M |
Operating revenue | 21.71%33.27M | 8.12%122.98M | 6.75%34.77M | 5.20%31.52M | 15.21%29.36M | 6.24%27.33M | 4.18%113.74M | 11.37%32.57M | 10.24%29.96M | -0.76%25.49M |
Cost of revenue | ||||||||||
Gross profit | ||||||||||
Operating expense | 5.96%33.12M | 10.52%132.48M | 15.66%35.46M | 9.98%33.67M | 10.37%32.1M | 5.88%31.26M | 3.26%119.87M | 5.57%30.66M | 3.80%30.61M | 0.35%29.09M |
Selling and administrative expenses | 9.20%25.36M | 11.04%100.43M | 14.60%26.71M | 12.99%25.97M | 13.01%24.53M | 3.44%23.22M | 6.02%90.45M | 4.94%23.31M | 5.61%22.98M | 3.86%21.71M |
-General and administrative expense | 9.20%25.36M | 11.04%100.43M | 14.60%26.71M | 12.99%25.97M | 13.01%24.53M | 3.44%23.22M | 6.02%90.45M | 4.94%23.31M | 5.61%22.98M | 3.86%21.71M |
Other operating expenses | -3.40%7.76M | 8.92%32.05M | 19.03%8.75M | 0.92%7.7M | 2.62%7.57M | 13.65%8.03M | -4.38%29.42M | 7.62%7.35M | -1.31%7.63M | -8.72%7.38M |
Operating profit | 103.83%150K | -55.03%-9.5M | -136.04%-689K | -230.62%-2.15M | 23.88%-2.74M | -3.48%-3.92M | 11.19%-6.13M | 837.25%1.91M | 71.91%-650K | -9.02%-3.6M |
Net non-operating interest income expense | -138.75%-191K | 56.98%-746K | 67.25%-207K | 34.72%-220K | 31.91%-239K | 80.68%-80K | -72.19%-1.73M | -76.04%-632K | -21.66%-337K | -62.50%-351K |
Non-operating interest income | -7.55%98K | 49.58%359K | -35.71%99K | 8.14%93K | --61K | --106K | --240K | --154K | --86K | --0 |
Non-operating interest expense | 55.38%289K | -44.02%1.11M | -61.07%306K | -26.00%313K | -14.53%300K | -55.07%186K | 96.03%1.97M | 118.94%786K | 52.71%423K | 62.50%351K |
Other net income (expense) | -99.80%3K | 0 | ||||||||
Special income (charges) | ---- | --0 | ---- | ---- | ---- | ---- | -99.80%3K | ---- | ---- | ---- |
-Gain on sale of property,plant,equipment | ---- | --0 | ---- | ---- | ---- | ---- | -99.80%3K | ---- | ---- | ---- |
Income before tax | 98.98%-41K | -30.37%-10.25M | -170.00%-896K | -140.02%-2.37M | 24.60%-2.98M | 4.74%-4M | -22.70%-7.86M | 925.81%1.28M | 32.90%-987K | -25.98%-3.95M |
Income tax | 150.00%40K | -3.24%-351K | -1,692.00%-398K | 103.69%15K | -23.81%16K | -23.81%16K | -357.58%-340K | -68.75%25K | -3,600.00%-407K | -34.38%21K |
Net income | 97.98%-81K | -31.60%-9.9M | -139.68%-498K | -311.03%-2.38M | 24.59%-3M | 4.83%-4.02M | -15.02%-7.52M | 634.04%1.26M | 60.27%-580K | -25.37%-3.97M |
Net income continuous Operations | 97.98%-81K | -31.60%-9.9M | -139.68%-498K | -311.03%-2.38M | 24.59%-3M | 4.83%-4.02M | -15.02%-7.52M | 634.04%1.26M | 60.27%-580K | -25.37%-3.97M |
Minority interest income | ||||||||||
Net income attributable to the parent company | 97.98%-81K | -31.60%-9.9M | -139.68%-498K | -311.03%-2.38M | 24.59%-3M | 4.83%-4.02M | -15.02%-7.52M | 634.04%1.26M | 60.27%-580K | -25.37%-3.97M |
Preferred stock dividends | ||||||||||
Other preferred stock dividends | ||||||||||
Net income attributable to common stockholders | 97.98%-81K | -31.60%-9.9M | -139.68%-498K | -311.03%-2.38M | 24.59%-3M | 4.83%-4.02M | -15.02%-7.52M | 634.04%1.26M | 60.27%-580K | -25.37%-3.97M |
Basic earnings per share | 0 | -30.00%-0.13 | -150.00%-0.01 | -200.00%-0.03 | 20.00%-0.04 | 16.67%-0.05 | -11.11%-0.1 | 732.31%0.02 | 50.00%-0.01 | -25.00%-0.05 |
Diluted earnings per share | 0 | -30.00%-0.13 | -150.00%-0.01 | -200.00%-0.03 | 20.00%-0.04 | 16.67%-0.05 | -11.11%-0.1 | 732.31%0.02 | 50.00%-0.01 | -25.00%-0.05 |
Dividend per share | ||||||||||
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- |